Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Pankreas
»
Neoplasms
30. June 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Esophagus
Pankreas
Neoplasms
Pancreatitis
Others
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 3034
Articles 1 - 20 / 60663
Endoscopic ultrasound-guided radiofrequency ablation for pancreatic cystic neoplasms: a comprehensive review.
Front Med (Lausanne)
Sun X, Ge N.
PMID: 42375187 [PubMed]
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types.
Mol Med
Gorbokon N, Teljuk K, Schraps N, Lennartz M, Rico SD, Kind S, Reiswich V, Viehweger F, Lutz F, Fraune C, Luebke AM, Menz A, Schlichter R, Krech T, Hinsch A, Burandt E, Sauter G, Simon R, Steurer S, Marx AH, Lebok P, Dum D, Minner S, Jacobsen F, Clauditz TS, Hackert T, Uzunoglu FG, Bernreuther C, Kluth M.
PMID: 42374173 [PubMed - indexed for MEDLINE]
Role of INSM1 expression in the diagnostic work-up of pancreatic acinar cell carcinoma with special reference to the differential diagnosis with neuroendocrine tumor.
Virchows Arch
Branca F, Marchiori D, Novarina S, Zaccaria M, Vanoli A, La Rosa S, Uccella S.
PMID: 42373833 [PubMed - as supplied by publisher]
Metabolic Reprogramming and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Mechanisms and Therapeutic Strategies.
Anticancer Res
Ahn D, Choi KC.
PMID: 42373267 [PubMed - indexed for MEDLINE]
Factors Associated With Refusal of Surgery for PDAC and Its Impact: An NCDB Analysis.
Anticancer Res
Manaise HK, Mahesh VA, Yadav A, Puri R, Aguayo-Merly A, Bowers J, Jimenez PB, Demirors B, Gabriel EM.
PMID: 42373259 [PubMed - indexed for MEDLINE]
Association Between Geriatric Nutritional Risk Index and Gemcitabine Plus Nab-Paclitaxel Continuation in Elderly Patients With Pancreatic Cancer.
Anticancer Res
Takigawa M, Miura C, Sato A, Hirai S, Kimura Y, Kinoshita M, Doi H, Masuda M.
PMID: 42373239 [PubMed - indexed for MEDLINE]
Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment.
JCO Precis Oncol
Moravec S, Barton LV, Suresh R, Hayward L, Schmidlen T, Rivera JNR, Basinski T, Alhassan S, Nardella N, Oraiqat A, Craig L, Cooper L, Blanquicett CJ, Maharaj SS, Blue K, Adams M, Kim R, Biachi De Castria T, Malafa M, Sinnamon AJ, Pereira AL, Kim DW, Hoffe S, Hodul PJ, Vadaparampil ST, Ho TT, Hicks JK, Snir M, Permuth JB.
PMID: 42372208 [PubMed - indexed for MEDLINE]
Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.
Cancer
Bruckner HW, Knopf E.
PMID: 42371807 [PubMed - in process]
Safety and efficacy of the MNK/VEGFR inhibitor JDB153 combined with the anti-PD-1 antibody serplulimab in patients with advanced pancreatic cancer refractory to standard treatment: a single-arm, phase Ib/II study protocol.
Front Pharmacol
Zhu X, Wei H, Cao D, Xu H.
PMID: 42371576 [PubMed]
Preoperative Systemic Pan-Immune-Inflammation Value Predicts Posthepatectomy Liver Failure After Laparoscopic Resection for Hepatocellular Carcinoma: A Retrospective Cohort Study.
J Inflamm Res
Wu X, Xu S, Zhang T, Xing Y, Min X, Wu J, Mao Q.
PMID: 42371494 [PubMed]
Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies.
Target Oncol
Valikovics AK, Bacsó D, Samaien N, das Virgens IPA, Szentes B, Agócs G, Obeidat M, Széll T, Hadaschik B, Hegyi P, Nyirády P, Szarvas T.
PMID: 42371314 [PubMed - as supplied by publisher]
Neoadjuvant Chemotherapy (FOLFIRINOX or Gemcitabine With Nab-Paclitaxel) for Borderline-Resectable Pancreatic Cancer: Long-Term Results of a Randomized Controlled Trial (NUPAT-01).
J Hepatobiliary Pancreat Sci
Yamaguchi J, Takami H, Yokoyama Y, Fujii T, Yamada S, Kawashima H, Ishikawa T, Maeda O, Ogawa H, Ebata T.
PMID: 42370451 [PubMed - as supplied by publisher]
Efficacy comparison of radical antegrade modular pancreatosplenectomy versus conventional distal pancreatectomy in the treatment of left-sided pancreatic cancer: a meta-analysis and systematic review.
Front Oncol
Wang J, Gu G, Zhang H, Zhong F.
PMID: 42370156 [PubMed]
Research progress on the etiology and pathogenesis of pancreatic cancer: a narrative review.
Front Oncol
Guo M, Han Q, Wang Z, Ya D, Wang X.
PMID: 42370145 [PubMed]
Immune - cell death index in hepatocellular carcinoma: a multi-omics and machine learning study for prognosis and immunotherapy prediction.
Front Immunol
Zhang Y, Zhao H, Zhai Y, Wang C, Wang Z, Liang R.
PMID: 42367826 [PubMed - indexed for MEDLINE]
Spatial immune archetypes in gastric and colorectal cancer: a proposed conceptual framework for immunotherapy resistance and therapeutic remodeling.
Front Immunol
Sun S, Zeng Y, Chen J, Zhong Y, Zhou T.
PMID: 42367754 [PubMed - indexed for MEDLINE]
Methodology Assessment of Endoscopic Ultrasound Radiofrequency Ablation (EUS-RFA) for Pancreatic Neoplasms: Results From an International Survey.
Dig Endosc
Lisotti A, Tacelli M, Crinò SF, Masciangelo G, Fusaroli P, Barthet M, Thosani N, Conti Bellocchi MC, Leblanc S, Khoury T, Arcidiacono PG, Facciorusso A, Caillol F, Giovannini M, Fuccio L, Samanta J, Teoh AYB, Ogura T, Havre RF, Krishna SG, Kovacevic B, Dhir V, Vilmann P, Lakhtakia S, Napoléon B, Pham KD.
PMID: 42366841 [PubMed - indexed for MEDLINE]
Molecular Subtype Identification and Prognostic Prediction of Pancreatic Cancer Based on m6A/m5C/m1A-Related Genes.
J Cell Mol Med
Wang Y, Hong X, Cao D, Wang M, Tuergong A, Liu H, Guo Y, Ting X, Liu X, Huo X, Si W.
PMID: 42366608 [PubMed - indexed for MEDLINE]
Safety evaluation of TOPAZ-1 and KEYNOTE-966 regimens in metastatic biliary tract cancer: a systematic review and meta-analysis.
Clin Exp Metastasis
Vitale E, Maistrello L, Ciccimarra F, Guven DC, Sahin TK, Monteiro FSM, de Luca R, Scaramuzzi M, Delcuratolo S, Brunetti O, Rizzo A, Brandi G.
PMID: 42366316 [PubMed - indexed for MEDLINE]
Serum TIMP-1 shows a potential association with metastatic disease in patients with pancreatic cancer: a pilot analysis without a healthy control cohort.
Clin Exp Med
Vecurkovska I, Roskovicova V, Gajdzik T, Soltes M, Maslankova J, Kocanova I, Katuchova J.
PMID: 42365195 [PubMed - as supplied by publisher]
Articles 1 - 20 / 60663
Page 1 of 3034
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy